GagPol-specific CD4+ T-cells increase the antibody response to Env by intrastructural help
View/ Open
Author
Nabi, Ghulam
Genannt Bonsmann, Michael Storcksdieck
Tenbusch, Matthias
Gardt, Oliver
Temchura, Vladimir
Überla, Klaus
Published Version
https://doi.org/10.1186/1742-4690-10-117Metadata
Show full item recordCitation
Nabi, Ghulam, Michael Storcksdieck Genannt Bonsmann, Matthias Tenbusch, Oliver Gardt, Dan H Barouch, Vladimir Temchura, and Klaus Überla. 2013. “GagPol-specific CD4+ T-cells increase the antibody response to Env by intrastructural help.” Retrovirology 10 (1): 117. doi:10.1186/1742-4690-10-117. http://dx.doi.org/10.1186/1742-4690-10-117.Abstract
Background: Immunization of rhesus macaques against Gag of SIV resulted in a more rapid appearance of Env antibodies after infection with SIV or SHIV challenge viruses although the vaccines lacked an Env component. We therefore explored whether T helper cells specific for internal HIV proteins could provide intrastructural help for Env-specific B cells and thus increase the Env antibody response. Results: Mice were immunized by adenoviral vector or DNA vaccines against GagPol and then boosted with virus-like particles (VLP) containing GagPol and Env. Env-specific antibody levels after the VLP booster immunizations were significantly higher in GagPol-immunized mice than in mock-vaccinated controls. Adoptive transfer of CD4+ T cells from GagPol-immunized mice also enhanced the Env antibody response to VLP immunization in the recipient mice. Depending on the presence of VLPs, co-cultivation of CD4+ T cells from GagPol-primed mice with BCR transgenic B cells specific for a protein presented on the surface of the VLPs also resulted in the activation of the B and T cells. Conclusions: Our study indicates that GagPol-specific T helper cells may provide intrastructural help for Env antibody responses. This cross-talk between immune responses directed against different components of the retroviral particle may be relevant for the immunopathogenesis of retroviral infections and allow to improve virus like particle vaccine approaches against HIV.Other Sources
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874777/pdf/Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material, as set forth at http://nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-use#LAACitable link to this page
http://nrs.harvard.edu/urn-3:HUL.InstRepos:11879400
Collections
- HMS Scholarly Articles [17918]
Contact administrator regarding this item (to report mistakes or request changes)